Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin, Serum ferritin decreased, Sinus congestion, Temperature intolerance
Clinical narrative: severe night sweats; hair loss; New skin rashes - similar to pityriasis rosea; Allergic laryngitis; New allergic reactions to pollen, dust, cedar, food groups; Chronic sinus congestion; Heat intolerance/Cold intolerance; Low ferritin not responsive to iron supplementation; Dizziness upon standing; Frequent palpitations; New allergic reactions to dust; New allergic reactions to cedar; New allergic reactions to pollen, dust, cedar, food groups. Chronic sinus congestion; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Feb2021 as dose 2, single (Lot number: EL9265) at the age of 32 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. Obscured by other product labelling, Location of injection: Arm Left), administration date: 08Jan2021, when the patient was 32-year-old, for COVID-19 Immunization. The following information was reported: LARYNGITIS ALLERGIC (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Allergic laryngitis"; SINUS CONGESTION (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Chronic sinus congestion"; DIZZINESS POSTURAL (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Dizziness upon standing"; PALPITATIONS (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Frequent palpitations"; TEMPERATURE INTOLERANCE (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Heat intolerance/Cold intolerance"; SERUM FERRITIN DECREASED (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Low ferritin not responsive to iron supplementation"; ALLERGY TO PLANTS (non-serious) with onset 01Mar2021, outcome "not recovered", described as "New allergic reactions to cedar"; DUST ALLERGY (non-serious) with onset 01Mar2021, outcome "not recovered", described as "New allergic reactions to dust"; SEASONAL ALLERGY (non-serious) with onset 01Mar2021, outcome "not recovered", described as "New allergic reactions to pollen, dust, cedar, food groups"; FOOD ALLERGY (non-serious) with onset 01Mar2021, outcome "not recovered", described as "New allergic reactions to pollen, dust, cedar, food groups. Chronic sinus congestion"; RASH (non-serious) with onset 01Mar2021, outcome "not recovered", described as "New skin rashes - similar to pityriasis rosea"; ALOPECIA (non-serious) with onset 01Mar2021, outcome "not recovered", described as "hair loss"; NIGHT SWEATS (non-serious) with onset 01Mar2021, outcome "not recovered", described as "severe night sweats". The events "severe night sweats", "hair loss", "new skin rashes - similar to pityriasis rosea", "allergic laryngitis", "new allergic reactions to pollen, dust, cedar, food groups", "chronic sinus congestion", "heat intolerance/cold intolerance", "low ferritin not responsive to iron supplementation", "dizziness upon standing", "frequent palpitations", "new allergic reactions to dust", "new allergic reactions to cedar" and "new allergic reactions to pollen, dust, cedar, food groups. chronic sinus congestion" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of night sweats, alopecia, rash, laryngitis allergic, seasonal allergy, sinus congestion, temperature intolerance, serum ferritin decreased, dizziness postural, palpitations, dust allergy, allergy to plants, food allergy.  Additional information: Initial symptom (starting after second dose): severe night sweats, hair loss. Further symptoms: Night sweats continued for approx 6 months. Stopped, then restarted after the booster in Oct2021. Lasted another 3-6 months and then stopped. New skin rashes - similar to pityriasis rosea, Allergic laryngitis, New allergic reactions to pollen, dust, cedar, food groups. Chronic sinus congestion. Heat intolerance, Cold intolerance, Low ferritin not responsive to iron supplementation - this should be investigated as there is a new and increasing population dealing with iron deficiency unresponsive to treatment. Dizziness upon standing, frequent palpitations, these symptoms had been present to the varying degrees since Mar2021. They are relapsing and remitting in nature. Prior to being administered the vaccine, the patient was a completely healthy 32-year-old with no fam history of autoimmune disease. It's almost as though her immune system had been completely rewired. The facility type for vaccine was pharmacy or drug store. No covid prior vaccination, no covid tested post vaccination, No known allergies prior to the vaccine. No other vaccine in four weeks. No other medications in two weeks.